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High glucose initiates calpain-induced necrosis
before apoptosis in LLC-PK1 cells
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Cells exposed to high ambient glucose concentrations are
subject to increases in intracellular calcium ([Ca2þ ]i). We
therefore considered it likely that the calcium-dependent
cysteine protease calpain would play a role in the
development of high glucose-induced cell injury. After 3 and
24 h, high glucose concentrations (25 mM D-glucose)
produced almost identical increases in the degree of necrotic
cell death in kidney proximal tubular epithelial cells (LLC-PK1)
compared to cells treated with control glucose (5 mM D-
glucose). Necrotic cell death could be restricted by inhibiting
the activity of calpain. High glucose-treated LLC-PK1 cells
were found to have significantly elevated [Ca2þ ]i
concentrations within 1 h, and elevated calpain activity
within 2 h compared to control treated cells. The DNA nick
sensor poly(ADP-ribose) polymerase (PARP) has previously
been shown to be an important driver of high glucose-
induced cell death, but here we found that although PARP
activity was increased after 24 h, it was unaltered after 3 h.
Furthermore, PARP inhibition with PJ-34 did not restrict early
high glucose-induced necrosis. Using a gene knockdown
strategy with small interference RNA, we found that silencing
calpain was effective in reducing the degree of early high
glucose-induced necrosis. We conclude that high glucose
concentrations evoke an early, calpain-mediated necrosis in
cultured proximal tubular cells that is PARP-independent,
and precedes the previously recognized activation of
apoptosis.
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We have previously reported that high glucose-induced
oxidative stress causes cell death in proximal tubular
epithelial cells (PTEC) via a pathway mediated by caspase
activation after 24–48 h.1 Four major molecular mechanisms
have been described to account for the development of high
glucose-induced cell injury as a consequence of reactive
oxygen species (ROS) generation and these consist of (i)
activation of protein kinase C, (ii) increases in hexosamine
pathway flux, (iii) increased advanced glycation end product
formation, and (iv) elevated polyol pathway flux.2 It is
thought that the driving force behind these developments is
the over-activation of the DNA nick sensor poly(ADP-ribose)
polymerase (PARP), leading to the inactivation of glycer-
aldehyde-3-phosphate dehydrogenase (GAPDH) via poly
(ADP-ribosyl)ation. GAPDH was originally considered to
be a classical glycolytic pathway protein with a pivotal role in
energy production within the cytosol. However, it is now
known that GAPDH can translocate to the nucleus where it
plays a crucial role in translational control, DNA replication
and repair.3 The poly(ADP-robosyl)ation of GAPDH occurs
within the nucleus causing a reduction in active GAPDH that
interrupts normal glucose metabolism leading to the events
listed above (i–iv,2,4,5), which can eventually result in the
release of proapoptotic factors from the mitochondria and
the activation of caspases. We considered it likely that PARP
over-activation would additionally cause a necrotic injury
due to nicotinamide adenine dinucleotide (PARP substrate)
and ATP depletion (required for nicotinamide adenine
dinucleotide resynthesis). Moreover, the generation of ROS
has been linked to the development of necrosis as well as
apoptosis.6 Clinical7 and experimental studies8,9 have re-
vealed an increase in nitrotyrosine deposition, a marker of
oxidative stress, in the diabetic kidney. This elevation in
nitrotyrosine staining in patients was not associated with a
rise in apoptosis7 leading us to speculate that the ensuing
injury was necrotic. However, the study of diabetes-induced
necrosis appears to of received little attention. This might in
part be due to difficultly in separating the toxic side effects of
streptozotocin treatment that can cause acute tubular
necrosis,10 from the development of necrosis that might
occur, as the result of induced diabetes. Finally, we thought it
likely that in high glucose-treated PTEC cultures, a second
family of cysteine proteases would be activated, namely the
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Ca2þ requiring cytosolic family known as calpains. This is
because a large number of studies have revealed that high
glucose treatment leads to a rise in intracellular calcium
([Ca2þ ]i) concentrations in cultured cells.
11–16 In order to
investigate this, we examined the same PTEC line as before
(LLC-PK1), but here we focused on the putative contribution
of calpain and PARP in glucose-induced cell injury.
RESULTS
Our initial findings showed that the degree of cytotoxicity in
LLC-PK1 cultures treated with high ambient glucose (25 mM
D-glucose) concentrations for 24 h was greatly elevated
compared to those cells treated with control concentrations
of glucose (5 mM D-glucose, Figure 1a). Inhibiting calpain
activity was found to significantly attenuate the degree
of high glucose induced injury (Figure 1a). The pan-
caspase inhibitor z-Asp-2,6-dichlorobenzoyloxymethylketone
(Bachem (UK) Ltd, St Helens, Merseyside, UK) was unable to
prevent high glucose-induced necrosis (Figure 1a), although
it clearly suppressed caspase activity because it almost
completely prevented the formation of caspase-3 specific a-
fodrin breakdown products (Figure 1b). In addition, the
calpain substrate PARP was found to be activated in LLC-PK1
cells subjected to high glucose concentrations for 24 h, and
inhibiting calpain strongly suppressed the activity of PARP
(Figure 2a). It is noticeable that calpeptin could also reduce
PARP activity in the control group. We speculate that this is
because our osmotic control (L-glucose) might (at 24 h) also
exert a calpain-mediated PARP-dependent injury. The
inhibition of PARP activity with PJ-34 was found to be
partially protective against high glucose-induced cytotoxicity
at the same time point (Figure 2b). Cellular calpain activity
was markedly higher after just 2 h in cultures incubated with
high glucose concentrations (Figure 3a). The mechanism of
this high glucose-induced calpain activation appears to be
due to a sudden rise in [Ca2þ ]i (Figure 3b). Therefore, we
decided to look at high glucose-induced necrosis after a
shorter incubation period. We were surprised to find that
high glucose concentrations could induce significant cyto-
toxicity after 3 h, and that this degree of injury remained
constant over a 24 h period (Figure 4a). The necrotic injury
achieved by high glucose-treated cultures as determined by
cell cytotoxicity (lactate dehydrogenase (LDH) release),
propidium iodide (PI) stained cells for microscopy and PI
staining determined by flow cytometry was variable, but
always a constant occurrence. Moreover, the degree of cell
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Figure 1 | Calpain but not caspase inhibition reduces high
glucose-induced cytotoxicity (24 h). (a) % cytotoxicity (necrotic
injury) determined by LDH in the cell culture media of LLC-PK1 cells
treated with 5 and 25 mM glucose in the presence and absence of the
calpain inhibitor calpeptin and the pan-caspase inhibitor
z-Asp-2,6-dichlorobenzoyloxymethylketone, 24 h, n¼ 6. (b) Illustrates
endogenous substrate breakdown under identical conditions as (a).
The density of the calpain/caspase fodrin breakdown product (145/
150 kDa doublet) appears greater in cells treated with high glucose
(25 mM D-glucose) for 24 h compared to those treated with control
glucose concentrations (5 mM D-glucose). The calpain inhibitor
calpeptin reduced the intensity of the calpain/caspase band fodrin
breakdown product and increases the intensity of the caspase only
band (120 kDa). (b) Five separate experiments run on five gels.
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Figure 2 | PARP activation is induced by high glucose
concentrations that can be prevented by calpain inhibition
(24 h). (a) PARP activity in LLC-PK1 cells treated with 5 and 25 mM
D-glucose in the presence and absence of the calpain inhibitor
calpeptin, 24 h, n¼ 12. (b) PARP inhibition reduces high
glucose-induced cytotoxicity (24 h). % Cytotoxicity (necrotic injury)
in high glucose-treated LLC-PK1 cells in the presence and absence of
the PARP inhibitor PJ-34, 24 h, n¼ 6.
656 Kidney International (2007) 71, 655–663
o r i g i n a l a r t i c l e SM Harwood et al.: High glucose initiates calpain-induced necrosis
cytotoxicity achieved after 3 h in high glucose was in itself
often variable (compare Figure 4a with Figure 6a), but it was
again a consistent and statistically significant finding. The
depletion of serum overnight in cultures did not improve
reproducibility (data not shown). The early high glucose-
induced rise in [Ca2þ ]i appears to be caused (at least in part)
by an influx of Ca2þ from the extracellular media because
removing extracellular Ca2þ by chelation with ethylene
glycol-bis(2-aminoethylether)-N,N,N´,N´-tetraacetic acid (EGTA)
greatly diminished high glucose-induced necrotic injury
(Figure 3c) and intracellular calpain activity (Figure 3d).
Selective calpain inhibition with PD 150606 (3-[4-Iodophe-
nyl]-2-mercapto-[Z]-2-propenoic acid), Merck Biosciences
Ltd, Beeston, Nottingham, UK) was successful at suppressing
the induction of early high glucose-induced cytotoxicity
(Figure 4b).
Further experimental evidence when staining cells with PI
confirmed that this early form of injury was necrotic in
nature. Visualization of a greater degree of injury was
apparent in cells treated with high glucose (Figure 5a–d) than
controls because a higher percentage of high glucose-treated
cells were found to stain positively for PI (Compare panels 5a
(all nuclei) and 5c (PI stained) with 5b (all nuclei) and 5d (PI
stained)). An inspection of eight randomly selected fields of
view from eight slides obtained from cells treated with
control or high glucose revealed that a significantly higher
percentage (%7s.d.) of the total cell number stained
positively for PI (5 mM 1.5771.2, 25 mM 9.4878.8, n¼ 8,
Po0.05). More precise quantitative analysis by flow cyto-
metry confirmed that this rise in PI staining was statistically
significant (Figure 5e), and that there was a reduction in the
appearance of an early marker of apoptosis (annexin V) on
dual labeled cells (Figure 5f).
Evidence that early necrotic cell death is evoked by an
oxidative stress mechanism was also demonstrated. The
superoxide dismutase mimetic TEMPOLTM, which is a
scavenger of ROS, was able to prevent the early rise in
glucose-induced cytotoxicity (Figure 6a). In addition,
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Figure 3 | Calpain activation by high glucose is Ca2þ mediated.
(a): In situ calpain activity (relative fluorescence units (RFUs) in vehicle
treated samples – RFUs in calpeptin-treated samples) in LLC-PK1 cells
treated with 5 and 25 mM D-glucose, 2 h, n¼ 12. (b) [Ca2þ ]i in LLC-PK1
cells pretreated with 10 mM fura-2-AM for 45 min before the addition
of 5 or 25 mM D-glucose (in the absence of FCS). Excitation (340/
380 nm) and (510 nm) emission fluorescence readings taken after a
50 min incubation at 201C, n¼ 6, see text for more detail. (c) %
Cytotoxicity (necrotic injury) in high glucose-treated LLC-PK1 cells in
the presence and absence of the cell impermeable calcium chelator
EGTA, 3 h, n¼ 6. (d) % Calpain activity in high glucose-treated
LLC-PK1 cells in the presence and absence of the calcium chelator
EGTA, 2 h, n¼ 24.
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Figure 4 | Necrotic injury occurs within 3 h and can be prevented
by calpain inhibition. (a) % Cytotoxicity (necrotic injury) in LLC-PK1
cells incubated with low and high glucose for 3 and 24 h, n¼ 6. (b) %
Cytotoxicity (necrotic injury) in the cell culture media of LLC-PK1 cells
treated with 5 and 25 mM glucose in the presence and absence of
calpain inhibitor PD 150606, 3 h, n¼ 6.
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TEMPOLTM was able to block the early activation of calpain
by high glucose (Figure 6b). Importantly, calpain gene
knockdown with small interference RNA (siRNA) was shown
to significantly reduce high glucose induced injury for both
calpain 2 and calpain 10. Evidence of calpain 2 isoform
knockdown is shown (Figure 7b) by the reduction of calpain
2 protein expression in cells transfected with large subunit
calpain 2 siRNA. The apparent reduction in the appearance
of calpain 2 in the calpain 10 gene knockdown samples is
likely to be due to antibody crossreactivity.
We found no detectable rise in PARP activity after 3 h high
glucose incubation (Figure 8a), in contrast to our 24 h
findings (Figure 2a), and we showed that PARP inhibition
had no discernable influence upon high glucose-induced
cytotoxicity (Figure 8b) leading us to believe that the early
high glucose-induced cytotoxicity is a PARP-independent
process.
DISCUSSION
In this study, our central finding is that high ambient glucose
concentrations can initiate an early form of necrotic cell
death in PTEC, within 3 h, and that this injury is mediated by
the calcium-activated cysteine protease calpain. We chose
LLC-PK1 cells for our PTEC model because we consider them
to be the ideal culture for the study of high glucose-induced
injury in vitro. This is because LLC-PK1 cells are able to
prosper under normal glycemic conditions, whereas primary
human PTEC and immortalized human kidney cells (HK-2)
require hyperglycemic (e.g. 17 mM glucose) conditions for
normal cell growth.17
Work by other groups,14,18–20 and our previous study1 has
revealed that high glucose concentrations can cause apoptotic
cell death after incubation periods of between 8 and 120 h. In
addition, there is also some evidence suggesting that
apoptosis can be evoked much earlier (E2 h) in both
pulmonary endothelial cells21 and in cultured dorsal root
ganglia neurons.22,23 However, very little has been reported
concerning the appearance of high glucose-induced necrosis
nor have there been any significant reports of early induction
of necrotic injury in PTEC in the diabetic rodent kidney. This
might be because these investigations have yet to be
undertaken. In general, necrotic cascades seem to be studied
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Figure 5 | Visualization and quantification of high
glucose-induced cell injury. Micrographs illustrating PI fluorescence
(c and d, cell impermeable in healthy cells, red nuclei staining)
counter-stained with 40,6-diamidino-2-phenylindole of the same view
(a and b, cell permeable in all cells, blue nuclei staining)
demonstrating that 25 mM D-glucose causes a greater percentage of
PI uptake in LLC-PK1 cells after a 3 h incubation than 5 mM D-glucose.
All 40,6-diamidino-2-phenylindole and PI exposure times were fixed
at 83 ms and 1.5 s, respectively, original magnification  200. The
rise in PI fluorescence in high glucose-treated LLC-PK1 cultures was
confirmed at the same time point quantitatively by flow cytometry
(e, n¼ 12). Cells co-stained with annexin V fluorescein isothiocyanate
revealed a significant reduction in the % of cells undergoing early
apoptosis (f, n¼ 12). Flow cytometry data derived from two
consecutive experiments (each n¼ 6).
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Figure 6 | TEMPOLTM prevents high glucose-induced necrosis and
clapain activation. (a) % Cytotoxicity (necrotic injury) in high
glucose-treated LLC-PK1 cells in the presence and absence of the free
radical scavenger TEMPOLTM, 3 h, n¼ 6. (b) Calpain activity in high
glucose-treated LLC-PK1 cells in the presence and absence of the free
radical scavenger TEMPOLTM, 3 h, n¼ 6.
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less than their apoptotic counterparts. An exception to this
being a study in cultured human mesangial cells that revealed
that high glucose induced a modest increase in cytotoxicity
after 24 h.20 Initially, we found that high glucose-induced
necrotic injury after a 24 h incubation, and that calpain, but
not caspase inhibition could significantly reduce the degree of
injury sustained (Figure 1a). The DNA repair protein PARP
was found to be significantly activated within 24 h of high
glucose treatment and this rise could be completely blocked
by inhibiting calpain activity (Figure 2a), whereas PARP
inhibition was found to lessen the degree of high glucose-
induced necrotic injury (Figure 2b). Other workers have
noted the essential role of PARP activation in the pathogene-
sis of high glucose-induced injury.2,4 However, as PARP was
not activated within 3 h of treatment with high glucose
concentrations (Figure 8a), and was only modestly elevated
after 24 h (Figure 2a), it seems likely that, in PTECs, early
high glucose-induced cytotoxicity is PARP independent. This
view is further supported by the inability of the PARP
inhibitor PJ-34 to attenuate early high glucose-induced
cytotoxicity (Figure 8b). This contrasts with the findings of
Soriano et al.21 who found that PARP was activated as early
as 2 h after treatment with high glucose in mouse pulmonary
endothelial cells. In another ROS-induced injury model
(arsenic trioxide), detectable activation of PARP-1 in human
cervical cancer cells occurred only after 36 h of treatment.24
We believe that it is calpain, and not PARP that is the main
driver of this early necrotic injury, partly because of the speed
at which calpain activation occurs in response to high glucose
and partly because of the effectiveness by which calpain
inhibition and calpain gene knockdown can attenuate this
injury. The ability of a ROS scavenger to prevent early, high
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the degree of early high glucose-induced cytotoxicity, 3 h, n¼ 12. (b) Demonstrates that calpain 2 gene knockdown reduces the expression of
pro-calpain (E50% reduction in band density compared to control siRNA-treated cells). Immunoblot shown is representative of four gels
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reduction (breakdown) of an endogenous substrate. Immunoblot shown is representative of two gels obtained from four separate
experiments.
0
0.2
0.4
0.6
0.8
1.0
1.2
PA
R
P 
ac
tiv
ity
0
5
10
15
20
25
30
35
40
5 mM glucose 25 mM glucose 5 mM glucose
+ 3 M PJ-34
25 mM glucose
+ 3 M PJ-34
5 mM glucose 25 mM glucose 5 mM glucose
+ 45 M calpeptin
25 mM glucose
+ 45 M calpeptin
%
 C
yt
ot
ox
ic
ity
 (L
DH
) P < 0.005 P < 0.005
a
b
Figure 8 | Early effects of high glucose are PARP-independent.
(a) PARP activity was found not to be stimulated by a 3 h incubation
in high glucose and that calpain inhibition with calpeptin did not
suppress PARP activity, n¼ 12. (b) Early high glucose-induced
cytotoxicity (necrotic injury) was unaffected by PARP inhibition with
PJ-34, 3 h, n¼ 12.
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glucose-induced cytotoxicity (Figure 6a) indicates that
oxidative stress mediates necrosis in addition to its known
induction of apoptotic cell death.1
Although little has been reported on the involvement
of calpain in high glucose-induced injury, it should not
perhaps be a surprising finding given the number of recent
citations showing that high ambient glucose concentrations
elevate [Ca2þ ]i.
10–15 Indeed, similar rises in [Ca2þ ]i in
response to high glucose were found in this study (Figure 3b)
within 50 min. Moreover, our finding that high glucose-
induced calpain activation is dependent, at least in part,
by calcium influx (Figure 3c and d), is supported by other
work that shows that high glucose can induce calcium influx
in human pancreatic islets, rat neurons and myocytes in
culture.14–16
In addition to LDH cytotoxicity measurements, the early
necrotic injury was visualized and quantified by PI staining
(Figure 5a–e). Early necrotic injury appears to precede the
induction of apoptosis because the percentage of cells stained
for an early apoptosis marker (annexin V) was found to be
significantly lower at the same time point (3 h, Figure 5f). An
interesting parallel was recently described using a brief
oxidant stress (3 min of 100 mM H2O2) on primary adult
cardiac fibroblasts. Flow cytometry analysis of dual PI and
annexin V-treated cells revealed that peroxide induced a rise
in necrosis and a reduction in apoptosis.25 It is of note that in
our earlier studies of this PTEC line, we found only modest
increases in high glucose-induced caspase-3 activity and
DNA fragmentation after 24 h, with much higher increases
seen after 48 h.1 Furthermore, inhibition of calpain with
calpeptin (24 h) caused an increase in specific caspase-3
activity (Figure 1b, lanes 2 and 5) that highlights that cross-
talk between calpain and caspase cascades occurs in these
cells as has been described for other cell lines.26–30,35–42 It
seems possible that in this high glucose model that cells are
committed to cell death and interventions with caspase or
calpain inhibitors is likely to shunt the death pathway from
apoptosis to necrosis and vice versa but would not be able to
prevent eventual cell death.
The activation of calpain in diabetic in vivo models in
mice31 and rats32–34 has been reported before with additional
findings that high glucose-induced calpain activation reduces
endothelial nitric oxide synthase function in mesenteric post-
capillary venules,33 and promotes cataractogenesis in the
spontaneous diabetic WBN/Kob rat.32 This study illustrates a
likely close association between the initial rise in [Ca2þ ]i in
less than 1 h (Figure 3b), the activation of calpain after 2 h
(Figure 3a), which leads to a previously unrecognized early
cytotoxic injury within 3 h, which is sustained for 24 h
(Figure 4a).
What is not clear from the work presented here is the
precise mechanism by which oxidative stress causes calcium
influx and calpain activation. Indeed, we have been unable to
prove conclusively that high glucose-induced calpain activa-
tion is directly linked to the rise in [Ca2þ ]i, although we do
consider our findings to be highly suggestive. What does
seem clear is that calpain is a crucial component in the
progression of this early necrotic injury. It seems likely
that there are parallel necrotic, apoptotic, and PARP-
dependent cascades, which can cross-talk and all can be
initiated by high glucose concentrations but the earliest death
reached by a sub-population of cells appears to be necrotic
(Figure 9).
Future work will consist of a detailed analysis of the
mechanism by which calpain is activated by high glucose
concentrations and to identify the individual calpain iso-
forms involved. However, because calpain activity can be
readily measured, it seems likely that of the many
ubiquitously expressed calpains (calpain 1, 2, 5, 10, and
13), we considered it probable that calpain 10 is one of the
least likely isoforms to be involved in early high glucose-
induced cytotoxicity, despite the known association of certain
calpain 10 polymorphisms with type II diabetes.43,44 This is
because the activity of calpain 10 has yet to be detected with
the type of in vitro assays with exogenous fluorescent
substrates that we have used in this study.45 Work by
Thompson and Goll46 has revealed that the rat kidney is
particularly rich in calpain 2 and we believe that it is the
uncontrolled activation of constitutively expressed calpain 2
by calcium influx is the main driver of early high glucose-
induced necrosis. However, we have not found conclusive
evidence for this, as we found that siRNA gene silencing for
calpain 2 and calpain 10 were both effective in attenuating
early high glucose-induced necrosis. In addition, as we
believe that our anti-calpain antibodies lack the specificity to
identify clearly individual isoform protein knockdown,
possibly because we are using cells of porcine origin, we are
therefore only able to assert the importance of calpain as a
mediator/inducer of injury rather than state the isoform
responsible.
To summarize, in this study, we have found that in
addition to the well-known apoptotic effects of high glucose
on PTEC, there is also an earlier, not previously recognized
necrotic pathway (within 3 h), that is mediated by the
activation of calpain probably via an increase in [Ca2þ ]i
concentrations. Furthermore, the early necrotic injury
precedes both the activation of PARP and the appearance
of apoptosis, indicating that neither PARP overactivation nor
the classical apoptotic pathways play a leading role in the
development of this early injury.
MATERIALS AND METHODS
Unless stated all chemicals were purchased from the Sigma-Aldrich
Chemical Company (Poole, Dorset, UK).
Cell culture
Porcine derived PTEC (ECACC, Salisbury, Wiltshire, UK) were
maintained in Dulbecco’s modified Eagle’s medium (DMEM)
containing 10% fetal calf serum (FCS), Biowest Ltd (Ringmer, East
Sussex, UK) and antibiotics (100 U/ml penicillin, 100 mg/ml
streptomycin, and 0.25 mg/ml amphotericin B) in 25 or 75 cm2
tissue culture flasks and incubated in a humidified air/CO2 (19:1)
environment at 371C. For all experiments cells were treated with
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5 mM D-glucose in DMEM (containing 20 mM L-glucose) or 25 mM
D-glucose and seeded in six-well or 96-well plates at a density to
ensure 90–100% confluency at the end of the study period.
Lysate preparation and protein determination
Cell pellets were resuspended in 150ml of cold assay buffer (63.2 mM
imadazole-HCL containing 10 mM of 2-mercaptoethanol, pH 7.3)
containing 10mM digitonin, 1 mM EGTA, 0.1 mM ethylenediaminete-
traacetic acid, pH 7.3, and kept on ice for 30 min with frequent
mixing. Samples were then centrifuged (16 000 g, 41C, 30 min,
Biofuge Fresco, Heraeus, Jencons PLS, Leighton Buzzard, UK), the
cell pellets discarded, and the lysates were frozen at 201C before
protein measurement by bicinchonic acid assay (Pierce BCA assay,
Perbio Science UK Ltd, Cramlington, Northumberland, UK).
Incubation media
Experiments were performed using enriched DMEM media
supplemented with 10% FCS with the addition of the calpain
inhibitors calpeptin and PD 150606, EGTA, PARP inhibitor PJ-34
(Merck Biosciences Ltd), and a pan-caspase inhibitor z-Asp-2,6-
dichlorobenzoyloxymethylketone, or controls (AnalaRTM grade
water, VWR International Ltd, Lutterworth, UK, or dimethyl
sulfoxide where appropriate).
Calpain activity assay in situ
Calpain activity was determined as previously described47 with one
slight modification in that a black sided, clear bottom, 96-well plate
was used instead of a six-well tissue culture plate with incubation
volumes adjusted accordingly from 2 ml to 100 ml.
Calpain and protease activation detection by Western blot of
pro-calpain and endogenous substrate breakdown products
(a-fodrin)
Lysates were prepared as above (Lysate preparation and protein
determination) and diluted 1:4 in running buffer before being boiled
for 5 min. Samples were placed on ice before gel loading (10 mg
protein/well for lysates, 20 ng/well of rat recombinant calpain 2,
Merck Biosciences Ltd). Proteins were separated on a pre-cast Bis-
Tris Gel (gradient 4–12%, from Invitrogen Ltd, Paisley, UK) and
electro-blotted onto a polyvinylidene difluoride membrane (Im-
mobion-PTM), before blocking overnight at 41C with 5% bovine
serum albumin. Membranes were then probed with rabbit anti-
calpain 2 (Sigma-Aldrich) or mouse anti-a-fodrin antibodies
(Affiniti Research Products Ltd, Mamhead, UK), both diluted
1:1000. The secondary antibody was either horseradish peroxidase
labeled anti-rabbit or anti-mouse immunoglobulin G (1:2000, Santa
Cruz Biotecnology Inc., Santa Cruz, CA, USA). Calpain, fodrin and
its breakdown products were then visualized using Western blotting
luminal reagent (Santa Cruz Biotechnology).
Quantification of cytotoxicity (necrotic cell death) by LDH
assay
LDH activity was measured in the incubation media before
(background control) and at the end of each experiment (3 or
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24 h) using a colorimetric assay (Cytotoxicity Detection kit, Roche
Diagnostics, Lewes, UK) as described before.48
Quantification of apoptotic and necrotic cell death with
annexin V and PI dual staining
Annexin V fluorescein isothiocyanate and PI (Becton Dickinson UK
Ltd, Cowley, Oxford, UK) dual staining were detected by flow
cytometry as described before.1
Study of necrotic cell death by fluorescent microscopy
Cells were incubated in a six-well plate containing a glass coverslip
and allowed to adhere overnight. DMEM (phenol red free)
containing 5 and 25 mM D-glucose was incubated for 3 h at 371C
in a humidified environment of air/CO2 (19:1) before the addition
of PI (10mM) for 10 min. Cells were then rinsed three times in
phosphate-buffered saline before mounting on a slide with 80 ml of
anti-fade reagent containing blue fluorescence 40,6-diamidino-2-
phenylindole counter-stain (Molecular Probes, Invitrogen Ltd).
Measurement of [Ca2þ ]i
LLC-PK1 cells were incubated overnight in black sided, clear
bottomed, 96-well plates. Sub-confluent cultures were then treated
with 10 mM fura-2-AM (Merck Bioscience Ltd) in phenol red free
DMEM (without FCS, with 0.01% PLURONICTM F-127 detergent,
Merck Biosciences Ltd) for 45 min, with shaking, in an incubator
(humidified air/CO2, 19:1). Media was removed from wells, washed
with 100 ml phosphate-buffered saline ( 3) and aspirated before
the addition of DMEM containing control or high glucose as
described above (see Cell culture). After a 50 min incubation at room
temperature, [Ca2þ ]i was detected by fura-2 fluorescence at 340/
380 nm excitation, 510 nm emission, with a microtiter plate reader
(BMG Fluorstar). Maximum and minimum [Ca2þ ]i ratios were
determined by the addition of 10 mM ionomycin and 5 mM EGTA,
respectively. Ratio values were converted into concentrations
according to the equation of Grynkiewicz et al.49
PARP activity
Commercial PARP cellular enzyme-linked immunosorbent assay
activity kit (Merck Biosciences Ltd) was used in accordance with the
manufacturer’s instructions. The assay determines PARP cellular
activity by detecting the conversion of biotinylated nicotinamide
adenine dinucleotide into nicotinamide and biotinylated-ADP
ribose polymers.
Gene knockdown of calpain 1, calpain 2, and calpain 10
LLC-PK1 cells were seeded into six-well plates in DMEM and left to
adhere overnight. The media was then replaced with 1 ml of serum-free
DMEM containing 100 nM of either calpain 1, calpain 2, calpain 10, or
a non-targeting control siRNA (SmartPool reagent, Dharmacon Inc.,
Lafayette, CO, USA, obtained from Perbio Science UK Ltd) and
transfections carried out using OligofectamineTM according to the
manufacturer’s instructions (Invitrogen Ltd). For each calpain isoform
a set of four pre-designed siRNA duplexes were obtained (Standard
siGenomeTM SMARTpool reagent). The SMARTpool dupexes targeted
calpain 1 large subunit, calpain 2 large subunit, and calpain 10,
respectively. The pooled siRNAs were used at a concentration (100 nM),
which has been demonstrated to provide efficient silencing of
the target gene while reducing off-target effects. Sequence information
of the pre-designed siRNA used in this study can be obtained
from Dharmacon at http://www.dharmacon.com/siGENOME/Item.
aspx?package=2794&template=1&geneId=15857&live Date=10/8/2005%
2012:00:00%20AM. After 4 h, 0.5 ml of DMEM containing 30% FCS
was added. After a further 24 h, the media was removed and replaced
with DMEM containing 5 mM D-glucose (with 20 mM L-glucose) or
25 mM D-glucose for 3 h.
Statistical evaluation
All data are presented as means7s.d. of n observations, where n
represents the number of samples studied. Data were analyzed by
one-way analysis of variance with Tukey’s post hoc test or unpaired
Student’s t-test where appropriate. When comparing the means of
two groups Po0.05 was considered significant.
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